ERBBs in the gastrointestinal tract: Recent progress and new perspectives
- 1 February 2009
- journal article
- review article
- Published by Elsevier in Experimental Cell Research
- Vol. 315 (4) , 583-601
Abstract
No abstract availableKeywords
This publication has 192 references indexed in Scilit:
- Multiple Mechanisms Are Responsible for Transactivation of the Epidermal Growth Factor Receptor in Mammary Epithelial CellsJournal of Biological Chemistry, 2008
- EGF receptor-independent action of TGF-α protects Naked2 from AO7-mediated ubiquitylation and proteasomal degradationProceedings of the National Academy of Sciences, 2008
- Survival of Cancer Cells Is Maintained by EGFR Independent of Its Kinase ActivityCancer Cell, 2008
- Reorganisation of Wnt-response pathways in colorectal tumorigenesisBritish Journal of Cancer, 2008
- Role of Epidermal Growth Factor and Other Growth Factors in the Prevention of Necrotizing EnterocolitisSeminars in Perinatology, 2008
- Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapyBritish Journal of Cancer, 2007
- Diacylglycerol kinase δ regulates protein kinase C and epidermal growth factor receptor signalingProceedings of the National Academy of Sciences, 2006
- Phosphorylation of TNF-α converting enzyme by gastrin-releasing peptide induces amphiregulin release and EGF receptor activationProceedings of the National Academy of Sciences, 2006
- EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinibProceedings of the National Academy of Sciences, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004